Osaterone

Osaterone is used primarily to manage benign prostatic hyperplasia (BPH) in dogs. Read more

Osaterone is used primarily to manage benign prostatic hyperplasia (BPH) in dogs.

Essential insights

• Androgen receptor antagonism: Osaterone acts as an antagonist at androgen receptors in the prostate gland.
• Reduction of prostate size: By blocking these receptors, osaterone inhibits the effects of androgens that contribute to prostate enlargement.
• Alleviation of symptoms: This action leads to a reduction in prostate size and alleviates symptoms associated with BPH, such as difficulty urinating.